Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progressionDanielle Croucher(University Health Network), Suzanne Trudel(Princess Margaret Cancer Centre)Nature CommunicationsNovember 3, 202110.1038/s41467-021-26598-wCited by 30SaveCiteExport RISWatch citationsRelated PapersPreclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma|Blood|2007|217Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study|Blood|2021|161